- Joined
- Feb 6, 2013
- Messages
- 23
- Reaction score
- 6
Hey PharmDs - how many of you have leveraged what you learned about pharmacogenomics and driving for a specific position regarding the importance of DNA Testing to ensure medications are metabolizing as intended?
Be sure to listen to these shows and share your thoughts:
http://pharmacypodcast.com/the-pharmacist-leveraging-pharmacogenomics/
http://pharmacypodcast.com/pharmacogenomics-and-new-opportunities-for-pharmacists/
In our second part of the Pharmacogenomics Pharmacy Podcast Series – we talk with Dr. Phillip Empey and Dr. James Coons with Pitt School of Pharmacy and UPMC – out of Pittsburgh PA.
Empey and Coons explain the concept of pharmacogenomics and describe advances in scientific knowledge and technology, which have led to innovations in personalized medicine.
We talk about the implications of pharmacogenomics data in guiding treatment decisions for patients and how pharmacists can lead these initiatives of proactively leveraging DNA Testing to better manage patient medication regimens.
REFERENCE SITE:
PharmGKB: https://www.pharmgkb.org/
Philip Empey, PharmD, PhD, BCPS,
Assistant Professor, University of Pittsburgh School of Pharmacy
[email protected]
James Coons, PharmD, BCPS (AQ-Cardiology)
Clinical Pharmacist, Cardiology, UPMC-Presbyterian Hospital; Associate Professor, University of Pittsburgh School of Pharmacy
[email protected]
For more information on leveraging Pharmacogenomics in your Pharmacy setting – contact:
Well Med Rx, LLC. (724) 836-6500
Be sure to listen to these shows and share your thoughts:
- Episode 198
http://pharmacypodcast.com/the-pharmacist-leveraging-pharmacogenomics/
- Episode 202
http://pharmacypodcast.com/pharmacogenomics-and-new-opportunities-for-pharmacists/
In our second part of the Pharmacogenomics Pharmacy Podcast Series – we talk with Dr. Phillip Empey and Dr. James Coons with Pitt School of Pharmacy and UPMC – out of Pittsburgh PA.
Empey and Coons explain the concept of pharmacogenomics and describe advances in scientific knowledge and technology, which have led to innovations in personalized medicine.
We talk about the implications of pharmacogenomics data in guiding treatment decisions for patients and how pharmacists can lead these initiatives of proactively leveraging DNA Testing to better manage patient medication regimens.
REFERENCE SITE:
PharmGKB: https://www.pharmgkb.org/
Philip Empey, PharmD, PhD, BCPS,
Assistant Professor, University of Pittsburgh School of Pharmacy
[email protected]
James Coons, PharmD, BCPS (AQ-Cardiology)
Clinical Pharmacist, Cardiology, UPMC-Presbyterian Hospital; Associate Professor, University of Pittsburgh School of Pharmacy
[email protected]
For more information on leveraging Pharmacogenomics in your Pharmacy setting – contact:
Well Med Rx, LLC. (724) 836-6500